{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:41Z","timestamp":1793134121539,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2787055"],"award-info":[{"award-number":["2787055"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.smrv.2025.102147","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:43:26Z","timestamp":1754415806000},"page":"102147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pharmacological impact on sleep architecture and polysomnographic measures in Restless Legs Syndrome: A systematic review"],"prefix":"10.1016","volume":"83","author":[{"given":"Maria P.","family":"Mogavero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias G.","family":"Karroum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Antelmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliviero","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferini-Strambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-3065","authenticated-orcid":false,"given":"Raffaele","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2025.102147_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib2","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1007\/s00415-024-12356-7","article-title":"A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists","volume":"271","author":"Antelmi","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41572-021-00311-z","article-title":"Restless legs syndrome","volume":"7","author":"Manconi","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.smrv.2025.102147_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chc.2020.08.010","article-title":"Restless legs syndrome in children and adolescents","volume":"30","author":"DelRosso","year":"2021","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.smrv.2025.102147_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.sleep.2021.10.025","article-title":"Morphological analysis of the brain subcortical gray structures in restless legs syndrome","volume":"88","author":"Mogavero","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/mds.30125","article-title":"Evidence of involvement of the calcitonin gene-related peptide in restless legs syndrome","volume":"40","author":"Mogavero","year":"2025","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/AJP.0000000000000133","article-title":"Painful restless legs syndrome: a severe, burning form of the disease","volume":"31","author":"Karroum","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.smrv.2025.102147_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101949","article-title":"Sensory aspects of restless legs syndrome: clinical, neurophysiological and neuroimaging prospectives","volume":"76","author":"Antelmi","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2025.102147_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sleep.2024.09.005","article-title":"Improvement in self-reported, but not actigraphic, sleep measures with suvorexant in people with well-controlled Restless Legs Syndrome and persistent insomnia","volume":"124","author":"Winkelman","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00415-022-11484-2","article-title":"Restless legs syndrome and cognitive function among adults: a systematic review and meta-analysis","volume":"270","author":"Wang","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsmc.2015.05.004","article-title":"Restless leg syndrome across the globe: epidemiology of the restless legs Syndrome\/Willis-Ekbom disease","volume":"10","author":"Koo","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.smrv.2025.102147_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.10.010","article-title":"World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)","volume":"26","author":"Ferri","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab092","article-title":"Scoring of large muscle group movements during sleep: an International Restless Legs Syndrome Study Group position statement","volume":"44","author":"Ferri","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae113","article-title":"Large muscle group movements during sleep in restless leg syndrome: neurophysiological and clinical implications","volume":"47","author":"Mogavero","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12896","article-title":"Peculiar lifespan changes of periodic leg movements during sleep in restless legs syndrome","volume":"29","author":"Ferri","year":"2020","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2025.102147_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.sleep.2024.01.024","article-title":"Changes in time structure of periodic leg movements during sleep in restless legs syndrome: effects of sex and age","volume":"115","author":"Mogavero","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.sleep.2024.08.023","article-title":"Exploring sex differences in periodic leg movements during sleep across the lifespan of patients with restless legs syndrome","volume":"122","author":"Mogavero","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib18","article-title":"Sex-based disparities in dopamine agonist response in patients with restless legs syndrome","author":"Mogavero","year":"2024","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2025.102147_bib19","article-title":"Restless sleep disorder, restless legs syndrome, and periodic limb movement disorder-Sleep in motion","volume":"57","author":"DelRosso","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.smrv.2025.102147_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109568","article-title":"Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis","volume":"27","author":"Mogavero","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.smrv.2025.102147_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302829","article-title":"Targeting the adenosinergic system in restless legs syndrome: a pilot, \"proof-of-concept\" placebo-controlled TMS-based protocol","volume":"19","author":"Lanza","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.smrv.2025.102147_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-819410-2.00004-7","article-title":"Sleep and homeostatic control of plasticity","volume":"184","author":"Lanza","year":"2022","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.961136","article-title":"Polysomnographic nighttime features of Restless Legs Syndrome: a systematic review and meta-analysis","volume":"13","author":"Geng","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00415-015-7994-y","article-title":"Defining the phenotype of restless legs syndrome\/Willis-Ekbom disease (RLS\/WED): a clinical and polysomnographic study","volume":"263","author":"Rinaldi","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5664\/jcsm.11390","article-title":"Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline","volume":"21","author":"Winkelman","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5664\/jcsm.10440","article-title":"Pharmacological responsiveness of periodic limb movements in patients with restless legs syndrome: a systematic review and meta-analysis","volume":"19","author":"Riccardi","year":"2023","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib27","series-title":"The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications","author":"Iber","year":"2007"},{"key":"10.1016\/j.smrv.2025.102147_bib28","series-title":"A manual of standardized terminology, techniques, and scoring System for sleep stages of human subjects","author":"Rechtschaffen","year":"1968"},{"key":"10.1016\/j.smrv.2025.102147_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/sleep\/32.2.139","article-title":"Sleep classification according to AASM and Rechtschaffen & Kales: effects on sleep scoring parameters","volume":"32","author":"Moser","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2869.2009.00785.x","article-title":"Sleep classification according to AASM and Rechtschaffen and Kales: effects on sleep scoring parameters of children and adolescents","volume":"19","author":"Novelli","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2025.102147_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105126","article-title":"Periodic leg movements during sleep associated with antidepressants: a meta-analysis","volume":"148","author":"Ferri","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.smrv.2025.102147_bib32","first-page":"75","article-title":"Statistical methods in meta-analysis","volume":"13","author":"Hedges","year":"1985","journal-title":"J Educ Stat"},{"key":"10.1016\/j.smrv.2025.102147_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.smrv.2025.102147_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/0962280211413451","article-title":"Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: a comparison between DerSimonian-Laird and restricted maximum likelihood","volume":"21","author":"Kontopantelis","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.smrv.2025.102147_bib35","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.smrv.2025.102147_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.smrv.2025.102147_bib37","first-page":"1229","article-title":"Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist","volume":"31","author":"Manconi","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.sleep.2008.05.014","article-title":"A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance","volume":"10","author":"Jama","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/33.6.793","article-title":"Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability","volume":"33","author":"Ferri","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11818-013-0622-0","article-title":"Periodic leg movements during sleep in PLMD and RLS patients with and without pramipexole treatment","volume":"17","author":"Thiedemann","year":"2013","journal-title":"Somnologie - Schlafforschung und Schlafmedizin"},{"key":"10.1016\/j.smrv.2025.102147_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sleep.2009.03.009","article-title":"Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: a polysomnographic randomized, double-blind, placebo-controlled study","volume":"11","author":"Inoue","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpsycho.2014.12.005","article-title":"Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist","volume":"95","author":"Galbiati","year":"2015","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.smrv.2025.102147_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sleep.2010.03.019","article-title":"Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep","volume":"12","author":"Manconi","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.sleep.2015.04.016","article-title":"Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?","volume":"16","author":"Rocchi","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3988\/jcn.2017.13.4.340","article-title":"Abnormal sleep Delta rhythm and interregional phase synchrony in patients with restless legs syndrome and their reversal by dopamine agonist treatment","volume":"13","author":"Choi","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/WNL.0b013e3182242d91","article-title":"Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome","volume":"77","author":"Manconi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2025.102147_bib47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ana.23565","article-title":"Dissociation of periodic leg movements from arousals in restless legs syndrome","volume":"71","author":"Manconi","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5665\/sleep.3558","article-title":"Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome","volume":"37","author":"Garcia-Borreguero","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/mds.23543","article-title":"Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome","volume":"26","author":"Manconi","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00702-009-0361-3","article-title":"Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome","volume":"117","author":"Saletu","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.smrv.2025.102147_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae310","article-title":"Evaluating the differential effects of dopamine agonists and Clonazepam on Large Muscle Group movements in restless legs syndrome","author":"Mogavero","year":"2025","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib52","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.sleep.2010.02.014","article-title":"Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study","volume":"11","author":"Oertel","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib53","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1212\/WNL.0000000000002649","article-title":"Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: an RCT","volume":"86","author":"Bauer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2025.102147_bib54","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/mds.28224","article-title":"Increased blood pressure dipping in restless legs syndrome with rotigotine: a randomized trial","volume":"35","author":"Chenini","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib55","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.0b013e3181e1ce73","article-title":"Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study","volume":"74","author":"Garcia-Borreguero","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2025.102147_bib56","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/mds.23771","article-title":"Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome","volume":"26","author":"Winkelman","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sleep.2018.02.002","article-title":"Treatment of restless legs syndrome\/Willis-Ekbom disease with the non-selective ENT1\/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis","volume":"45","author":"Garcia-Borreguero","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib58","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/mds.28668","article-title":"A randomized, placebo-controlled crossover Study with dipyridamole for restless legs syndrome","volume":"36","author":"Garcia-Borreguero","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2017.03.012","article-title":"Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel","volume":"34","author":"Garcia-Borreguero","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40263-023-01055-y","article-title":"Treatment of sleep, motor and sensory symptoms with the orexin antagonist suvorexant in adults with idiopathic restless legs syndrome: a randomized double-blind crossover proof-of-concept Study","volume":"38","author":"Garcia-Borreguero","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.smrv.2025.102147_bib61","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/sleep\/29.12.1587","article-title":"Different periodicity and time structure of leg movements during sleep in narcolepsy\/cataplexy and restless legs syndrome","volume":"29","author":"Ferri","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib62","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/sleep\/29.9.1183","article-title":"PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution","volume":"29","author":"Pennestri","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.sleep.2024.05.011","article-title":"Dopamine agonists in restless leg syndrome treatment and their effects on sleep parameters: a systematic review and meta-analysis","volume":"119","author":"Yeh","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018674","article-title":"Treating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort Study with 3.4 years of Follow-Up","volume":"10","author":"Gao","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.smrv.2025.102147_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01104-2019","article-title":"EAN\/ERS\/ESO\/ESRS statement on the impact of sleep disorders on risk and outcome of stroke","volume":"55","author":"Bassetti","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.smrv.2025.102147_bib66","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.smrv.2025.102147_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/bs.irn.2024.10.012","article-title":"Clinical pharmacology of neuropathic pain","volume":"179","author":"Rosner","year":"2024","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.smrv.2025.102147_bib69","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2016.1202764","article-title":"Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use","volume":"16","author":"Calandre","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.smrv.2025.102147_bib70","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM Scoring Manual Updates for 2017 (Version 2.4)","volume":"13","author":"Berry","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.sleep.2024.03.009","article-title":"Restless legs syndrome in patients with obstructive sleep apnea: association between apnea severity and symptoms of depression, insomnia, and daytime sleepiness","volume":"117","author":"Kim","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib72","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/jsr.12495","article-title":"Gabapentin acutely increases the apnea-hypopnea index in older men: data from a randomized, double-blind, placebo-controlled study","volume":"26","author":"Piovezan","year":"2017","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2025.102147_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/sleep\/16.4.327","article-title":"Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo","volume":"16","author":"Walters","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib74","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2025.102147_bib75","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","article-title":"Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension","volume":"12","author":"Trenkwalder","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib76","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s40263-016-0372-1","article-title":"Sleep and quality of life under prolonged release Oxycodone\/Naloxone for severe restless legs syndrome: an analysis of secondary efficacy variables of a Double-Blind, randomized, placebo-controlled Study with an open-label extension","volume":"30","author":"Oertel","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.smrv.2025.102147_bib77","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/add.14964","article-title":"Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis","volume":"115","author":"Walley","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.smrv.2025.102147_bib78","series-title":"The ASAM criteria: treatment for addictive, substance-related, and co-occurring conditions","author":"Mee-Lee","year":"2013"},{"key":"10.1016\/j.smrv.2025.102147_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad273","article-title":"Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?","volume":"47","author":"Ferre","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib80","article-title":"Baseline and 1-year longitudinal data from the National Restless Legs Syndrome Opioid Registry","volume":"44","author":"Winkelman","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib81","doi-asserted-by":"crossref","first-page":"e1520","DOI":"10.1212\/WNL.0000000000206855","article-title":"Long-term safety, dose stability, and efficacy of opioids for patients with restless legs syndrome in the national RLS opioid registry","volume":"100","author":"Winkelman","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2025.102147_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5664\/jcsm.10524","article-title":"Opioids and restless legs syndrome: a double-edged sword","volume":"19","author":"Winkelman","year":"2023","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/ene.14582","article-title":"Socioeconomic impact of restless legs syndrome and inadequate restless legs syndrome management across European settings","volume":"28","author":"Trenkwalder","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.smrv.2025.102147_bib84","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.sleep.2015.08.006","article-title":"Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome","volume":"16","author":"Schneider","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sleep.2021.08.030","article-title":"Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder","volume":"87","author":"DelRosso","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.sleep.2024.08.004","article-title":"Response to iron supplementation is similar between boys and girls with pediatric sleep movement disorders","volume":"122","author":"DelRosso","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae095","article-title":"Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial","volume":"47","author":"Earley","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International restless legs syndrome study group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib89","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.sleep.2024.09.017","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: a meta-analysis of 537 patients","volume":"124","author":"Qadri","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae022","article-title":"Efficacy of intravenous iron for restless legs syndrome-moving beyond monotherapy and into the \"real world\"","volume":"47","author":"Matar","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5664\/jcsm.11332","article-title":"Serum ferritin measurements differ according to the assay used: implications for iron therapy in restless legs syndrome","volume":"21","author":"Silber","year":"2025","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2025.102147_bib92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10072-022-06397-x","article-title":"Clonazepam for the management of sleep disorders","volume":"44","author":"Raggi","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.smrv.2025.102147_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14569","article-title":"Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: time for new therapeutic approaches?","volume":"30","author":"Mogavero","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.smrv.2025.102147_bib94","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/sleep\/30.12.1779","article-title":"Time structure analysis of leg movements during sleep in REM sleep behavior disorder","volume":"30","author":"Manconi","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2025.102147_bib95","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079225001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079225001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:05:23Z","timestamp":1777608323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079225001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":95,"alternative-id":["S1087079225001005"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102147","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological impact on sleep architecture and polysomnographic measures in Restless Legs Syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2025.102147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102147"}}